Lilyanna, Shera <br/><br/>
GYY4137 attenuates remodeling, preserves cardiac function and modulates the natriuretic peptide response to ischemia.  [electronic resource] 

 -  Journal of molecular and cellular cardiology  Oct 2015 
 - 27-37 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1095-8584 
<br/><br/><label>Standard No.: </label>10.1016/j.yjmcc.2015.07.028  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Atrial Natriuretic Factor--metabolism<br/>Cardiotonic Agents--administration & dosage<br/>Humans<br/>Hydrogen Sulfide--metabolism<br/>Ischemia--drug therapy<br/>Morpholines--administration & dosage<br/>Myocardial Infarction--drug therapy<br/>Natriuretic Peptide, Brain--metabolism<br/>Organothiophosphorus Compounds--administration & dosage<br/>Rats<br/>Ventricular Dysfunction, Left--drug therapy<br/>Ventricular Remodeling--drug effects